• 62% revenue growth to $36.9M, exceeding guidance
• 150% EBITDA increase to $5.2M, above guidance
• 270% NPBT growth to $3.9M
• 15% increase in software and SMA revenues to $4.6M

Austco Healthcare Ltd has reported exceptional financial results for the first half of the 2025 financial year (1HFY25). The company achieved record revenue of $36.9 million, representing a 62% increase compared to the prior corresponding period (pcp). This strong performance was underpinned by the successful integration of two recent acquisitions, Teknocorp and Amentco, which contributed $11.9 million in revenue. The company also experienced robust organic growth in Asia and North America. Austco's software and SMA (Subscription, Maintenance, and Assurance) revenues grew by 15% to $4.6 million, highlighting the increasing importance of these high-margin offerings. The company's EBITDA increased by 150% to $5.2 million, exceeding the top end of its guidance, while net profit before tax grew by 270% to $3.9 million. Austco remains debt-free, with $14.9 million in cash as of 31 December 2024. The company's strategic acquisitions, focus on innovation, and growing software and recurring revenue streams have been the key drivers of its exceptional financial performance in the first half of FY2025.

Austco Healthcare reported record revenue of $36.9 million and EBITDA of $5.2 million for the first half of the 2025 financial year, exceeding the top end of its previous guidance.

Austco Healthcare is positioned for meaningful growth, driven by its strategic vision, commitment to innovation, and focus on maximizing revenue streams to drive profitability and long-term value for shareholders. The company will continue to prioritize innovation and product development, invest in high-margin software and SMA solutions, and pursue strategic mergers and acquisitions to strengthen its competitive edge and drive sustainable growth.